Tolaasins A−E, Five New Lipodepsipeptides Produced by Pseudomonas tolaasii
Citations Over TimeTop 14% of 2004 papers
Abstract
Pseudomonas tolaasii, the causal organism of brown blotch disease of Agaricus bisporus and of the yellowing of Pleurotus ostreatus, was shown to produce in culture tolaasin I (1), tolaasin II (2), and five other minor metabolites, tolaasins A, B, C, D, and E (3-7). These compounds were demonstrated to be important in the development of the disease symptoms. This paper reports on the structural elucidation, based essentially on NMR studies and MS spectra, and biological activity of the above lipodepsipeptides (3-7). All the above analogues showed differences in the peptide moiety, as observed in other lipodepsipeptides of bacterial origin, and maintained the beta-hydroxyoctanoyl phi chain at the N-terminus, except tolaasin A, in which the acyl moiety was a gamma-carboxybutanoyl phi moiety. Among the target microorganisms used (fungi, yeast, and bacteria) the Gram-positive bacteria were the most sensitive, although the antimicrobial activity appeared to be correlated to the structural modification in the different analogues. The structure-activity relationships of these toxins are discussed.
Related Papers
- → Diseases of White Button Mushroom (Agaricus bisporus)- A Potential Threat to Mushroom Industry(2021)22 cited
- → Agaricus Bisporus: An assessment of its carcinogenic potency(1993)23 cited
- → USING SOME MATHEMATICAL MODELS IN MODELING MUSHROOM DRYING (\textit{AGARICUS BISPORUS})(2020)3 cited
- → CHEMICAL COMPOSITION AND THE ANTIOXIDANT ACTIVITY OF TWO EDIBLE MUSHROOMS(2018)2 cited
- The two life cycles of Agaricus bisporus. Mushroom biology and mushroom product.(1996)